We're committed to providing you with the very best cancer care, and your safety continues to be a top priority. With this in mind, we’ve put in place many new procedures, including a limited visitor policy and are not allowing patients to have people with them during appointments. This is just one more way of ensuring your safety and that of our staff. Read more
Instructor, Department of Diagnostic Pathology, Keio University Hospital, Tokyo, Japan
Emoto K, Eguchi T, Tan KS, Takahashi Y, Aly RG, Rekhtman N, Travis WD, Adusumilli PS, Travis WD. Expansion of the concept of micropapillary adenocarcinoma to include a newly recognized filigree pattern as well as the classical pattern based on 1468 stage I lung adenocarcinomas. J Thorac Oncol. 2019;14(11):1948-1961.
Johnston RP, Emoto K, Dux J, Travis WD, Adusumilli PS. Predicting spread through air spaces (STAS) preoperatively: can imaging help? J Thorac Dis. 2019;11(Suppl 15):S1938-S1941.
Qu Y, Emoto K, Eguchi T, Aly RG, Zheng H, Chaft JE, Tan KS, Jones DR, Kris MG, Adusumilli PS, Travis WD. Pathologic assessment after neoadjuvant chemotherapy for non-small cell lung cancer: Importance and implications of distinguishing adenocarcinoma from squamous cell carcinoma. J Thorac Oncol. 2019 Mar;14(3):482-493.
Emoto K, Vaghjiani RG, Adusumilli PS. Tracing the origin, tracking the evolution, and the treatment of the future. J Thorac Cardiovasc Surg. 2018;155(3):1203-4.